{
    "id": "professional_medicine-232",
    "question": "A 26-year-old male police officer comes to the office for an annual health maintenance examination. He is physically active and feels well, but he notes that his asthma has been more active during the past month. He says that he has had to use his albuterol inhaler one to two times daily for wheezing and chest tightness. He has not had gastroesophageal reflux symptoms, productive cough, or fever. Medical history is remarkable for atopic allergies, especially to pollen and cats. He has had coldand exercise-induced asthma for the past 14 years. He takes no other medications. He is 188 cm (6 ft 2 in) tall and weighs 90 kg (200 lb); BMI is 25 kg/m2 . Vital signs are temperature 37.0\u00b0C (98.6\u00b0F), pulse 70/min, respirations 12/min, and blood pressure 120/76 mm Hg. Physical examination shows no abnormalities except for scattered rhonchi and wheezes with forced expiration. Peak expiratory flow rate is 240 L/min. Which of the following is the most appropriate management?",
    "options": {
        "A": "Chest x-ray",
        "B": "Fexofenadine therapy",
        "C": "Increased use of the albuterol inhaler",
        "D": "Initiation of a daily corticosteroid inhaler"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"The patient presents with symptoms of asthma exacerbation, including wheezing and chest tightness, which have been occurring one to two times a day. The patient has a history of exercise-induced asthma, which suggests that physical activity may be triggering the symptoms. The patient's peak expiratory flow rate is 240 L/min, which is below the normal range for a healthy individual. This indicates that the patient's airway obstruction is significant enough to affect lung function. Given the patient's symptoms and lung function, the most appropriate management would be to address the underlying asthma exacerbation. The patient's allergies to pollen and cats are relevant, but there is no indication of gastroesophageal reflux disease (GERD) symptoms, which is often associated with asthma exacerbations. The patient's BMI is 25 kg/m2, which falls within the overweight category, but this is not directly related to the asthma management. The patient is already using albuterol inhaler one to two times daily, which is a common treatment for acute asthma exacerbations. Increasing the use of the albuterol inhaler (option C) may not be the most effective management strategy, as it is already being used to control symptoms. Option A, a chest x-ray, is not necessary for the management of asthma exacerbations and may not provide any additional benefit. Option B, fexofenadine therapy, is an antihistamine that may be useful for managing allergic symptoms, but it does not address the underlying asthma exacerbation. Therefore, the most appropriate management would be option D, initiation of a daily corticosteroid inhaler, which can help reduce inflammation and prevent future exacerbations.\"} \"answer_choice\": \"D\"",
    "snippets": [],
    "scores": [],
    "execution_time": 59.44682168960571
}